151 related articles for article (PubMed ID: 37023952)
1. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer.
Fathi D; Elballal MS; Elesawy AE; Abulsoud AI; Elshafei A; Elsakka EGE; Ismail A; El-Mahdy HA; Elrebehy MA; Doghish AS
Life Sci; 2023 Jun; 322():121667. PubMed ID: 37023952
[TBL] [Abstract][Full Text] [Related]
2. The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer.
Doghish AS; El-Husseiny AA; Abdelmaksoud NM; El-Mahdy HA; Elsakka EGE; Abdel Mageed SS; Mahmoud AMA; Raouf AA; Elballal MS; El-Dakroury WA; AbdelRazek MMM; Noshy M; El-Husseiny HM; Abulsoud AI
Pathol Res Pract; 2023 Jun; 246():154529. PubMed ID: 37196470
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
Hu M; Zhu S; Xiong S; Xue X; Zhou X
Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
[TBL] [Abstract][Full Text] [Related]
4. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review.
Elrebehy MA; Al-Saeed S; Gamal S; El-Sayed A; Ahmed AA; Waheed O; Ismail A; El-Mahdy HA; Sallam AM; Doghish AS
Int J Biol Macromol; 2022 Aug; 214():583-600. PubMed ID: 35768045
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
6. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
7. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
[TBL] [Abstract][Full Text] [Related]
8. Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).
Shao Z; Gao D; Chen L; Ding W; Yu Q
Oncol Rep; 2020 Oct; 44(4):1314-1321. PubMed ID: 32945460
[TBL] [Abstract][Full Text] [Related]
9. The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.
Hegazy M; Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Abdelghany TM; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Doghish AS
Pathol Res Pract; 2023 Jun; 246():154510. PubMed ID: 37167812
[TBL] [Abstract][Full Text] [Related]
10. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review.
Ismail A; El-Mahdy HA; Abulsoud AI; Sallam AM; Eldeib MG; Elsakka EGE; Zaki MB; Doghish AS
Int J Biol Macromol; 2023 Jan; 224():1541-1565. PubMed ID: 36328268
[TBL] [Abstract][Full Text] [Related]
11. miRNAs as potential game-changers in melanoma: A comprehensive review.
Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
[TBL] [Abstract][Full Text] [Related]
12. A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance.
Doghish AS; Hegazy M; Ismail A; El-Mahdy HA; Elsakka EGE; Elkhawaga SY; Elkady MA; Yehia AM; Abdelmaksoud NM; Mokhtar MM
Pathol Res Pract; 2023 May; 245():154442. PubMed ID: 37031532
[TBL] [Abstract][Full Text] [Related]
13. Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.
Fang Z; Zhang L; Liao Q; Wang Y; Yu F; Feng M; Xiang X; Xiong J
J Exp Clin Cancer Res; 2017 Jan; 36(1):17. PubMed ID: 28114950
[TBL] [Abstract][Full Text] [Related]
14. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
Liu L; Tian YC; Mao G; Zhang YG; Han L
Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
[TBL] [Abstract][Full Text] [Related]
15. miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model.
Streleckiene G; Inciuraite R; Juzenas S; Salteniene V; Steponaitiene R; Gyvyte U; Kiudelis G; Leja M; Ruzgys P; Satkauskas S; Kupcinskiene E; Franke S; Thon C; Link A; Kupcinskas J; Skieceviciene J
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013265
[TBL] [Abstract][Full Text] [Related]
16. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
17. Wnt-regulating microRNAs role in gastric cancer malignancy.
Ashrafizadeh M; Rafiei H; Mohammadinejad R; Farkhondeh T; Samarghandian S
Life Sci; 2020 Jun; 250():117547. PubMed ID: 32173311
[TBL] [Abstract][Full Text] [Related]
18. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer.
Zheng L; Kang L; Cheng Y; Cao J; Liu L; Xu H; Gao L
Pathol Oncol Res; 2021; 27():581542. PubMed ID: 34385891
[TBL] [Abstract][Full Text] [Related]
19. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
20. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
